Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Chemotherapy-induced Toxicities in Breast Cancer
NCT06186700Phase 2Completed
- Sponsor
- Mansoura University
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline in breast cancer, sponsored by Mansoura University. Started Dec 2023; status: completed.
02
Drugs
pentoxifylline
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06186700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06186700.